Endostatin    (DrugBank: Endostatin)

1 disease
IDDisease name (Link within this page)Number of trials
34Neurofibromatosis1

34. Neurofibromatosis    [ 120 clinical trials,   182 drugs,   (DrugBank: 72 drugs),   84 drug target genes,   194 drug target pathways]
Searched query = "Neurofibromatosis", "NF1", "von Recklinghausen disease", "NF2"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 120 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02104323
(ClinicalTrials.gov)
January 201426/3/2014Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related TumorsRecombinant Human Endostatin Injection Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors by Continuous Intravenous PumpingVestibular Schwannoma;Neurofibromatosis Type 2Drug: EndostatinBeijing Tiantan HospitalShandong Simcere-Medgenn Bio-pharmaceutical Co., LtdCompleted16 Years30 YearsAll20Phase 2China